CDSCO Waives Phase 3 Trials for Generic Lenacapavir HIV Drug
The Central Drugs Standard Control Organisation (CDSCO) has waived the requirement for local Phase 3 clinical trials for generic versions of lenacapavir, a breakthrough HIV prevention drug, moving India significantly…
